Assignee
APTINYX INC
US·25 granted patents·13 pending applications·298 citations·filing 2014–2022
Top patents by PatentIndex Score
38 records- 0199US10150769B2Spiro-lactam NMDA modulators and methods of using sameAPTINYX INC·Filed 2018·Granted Dec 11, 2018·20 cites·3 claims
- 0298US10195179B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Feb 5, 2019·18 cites·10 claims
- 0398US9925169B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Mar 27, 2018·19 cites·6 claims
- 0498US9512134B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Dec 6, 2016·35 cites·34 claims
- 0597US11077094B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2019·Granted Aug 3, 2021·7 cites·2 claims
- 0697US10052308B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2016·Granted Aug 21, 2018·19 cites·9 claims
- 0796US10918637B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Feb 16, 2021·10 cites·18 claims
- 0896US10441572B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2018·Granted Oct 15, 2019·11 cites·2 claims
- 0996US10441571B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2018·Granted Oct 15, 2019·12 cites·2 claims
- 1096US10196401B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Feb 5, 2019·18 cites·10 claims
- 1196US9932347B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 3, 2018·19 cites·6 claims
- 1296US9828384B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Nov 28, 2017·24 cites·63 claims
- 1395US11028095B2Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Jun 8, 2021·10 cites·20 claims
- 1495US10961189B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Mar 30, 2021·10 cites·25 claims
- 1594US9758525B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Sep 12, 2017·23 cites·45 claims
- 1694US9738650B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Aug 22, 2017·22 cites·37 claims
- 1792US10273239B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 30, 2019·10 cites·20 claims
- 1892US10253032B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 9, 2019·10 cites·20 claims
- 1987US11376250B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2020·Granted Jul 5, 2022·1 cites·20 claims
- 2076US2023312591A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2022·Application pending·0 cites
- 2175US2023131402A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2022·Application pending·0 cites
- 2273US11427585B2Spiro-lactam NMDA modulators and methods of using sameAPTINYX INC·Filed 2020·Granted Aug 30, 2022·0 cites·9 claims
- 2372US11530223B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2021·Granted Dec 20, 2022·0 cites·12 claims
- 2472US2021155632A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2020·Application pending·0 cites
- 2570US2019330209A1Spiro-lactam nmda modulators and methods of using sameAPTINYX INC·Filed 2018·Application pending·0 cites
- 2667US11370790B2Spiro-lactam NMDA modulators and methods of using sameAPTINYX INC·Filed 2017·Granted Jun 28, 2022·0 cites·21 claims
- 2765US2022098211A1Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2021·Application pending·0 cites
- 2864US11512051B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2021·Granted Nov 29, 2022·0 cites·13 claims
- 2963US2018215767A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2018·Application pending·0 cites
- 3063US2018244680A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2018·Application pending·0 cites
- 3161US2018179218A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2017·Application pending·0 cites
- 3256US11299495B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 12, 2022·0 cites·18 claims
- 3356US2023210851A1Spiro-lactam compounds and methods of treating viral infections using the sameAPTINYX INC·Filed 2021·Application pending·0 cites
- 3455US2021308101A1Methods of treating fibromyalgiaAPTINYX INC·Filed 2020·Application pending·0 cites
- 3553US2021322393A1Methods of treating cognitive impairment associated with neurodegenerative diseaseAPTINYX INC·Filed 2020·Application pending·0 cites
- 3652US11578072B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2019·Granted Feb 14, 2023·0 cites·15 claims
- 3750US2022273629A1Methods of treating disorders associated with elevated levels of antibodies that interact with the nmda receptorAPTINYX INC·Filed 2020·Application pending·0 cites
- 3846US2021047324A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APTINYX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →